Diet and chemical defenses of the Sonoran Desert toads
Marina D. Luccioni, Jules T. Wyman, Edgard O. Espinoza, Lauren A. O’connell
bioRxiv (Cold Spring Harbor Laboratory) October 9, 2023 preprint DOI: 10.1101/2023.10.06.561297 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational cohort |
|---|---|
| Population | Wild Sonoran Desert Toads (Incilius alvarius) and sympatric anurans from native and urban habitats around Tucson, Arizona |
| Keywords | Sympatric speciation Habitat Toad Ecology Desert philosophy Zoology Feeding behavior |
| Citations | 2 |
| Key findings | Diet is not directly linked to 5-MeO-DMT production in Sonoran Desert Toads, supporting endogenous synthesis or a microbial symbiont as the source. |
Abstract
Abstract The Sonoran Desert Toad ( Incilius alvarius ) is the only animal known to secrete the psychedelic compound 5-MeO-DMT as a chemical defense, but the source of 5-MeO-DMT in I. alvarius remains unknown. Some amphibians endogenously produce chemical defenses while others acquire them from specialized diets. In this study we analyzed toxin gland secretions and diet profiles from wild I. alvarius and sympatric anurans from native and urban habitats around Tucson, Arizona to explore possible links between diet and 5-MeO-DMT production. All I. alvarius secreted high concentrations of 5-MeO-DMT, whereas other sympatric toads did not. The diet of I. alvarius was similar to that of sympatric anurans, indicating that I. alvarius does not exhibit relative dietary specialization. Slight dietary differences between I. alvarius in native and urbanized habitats were observed. Taken together, these lines of evidence suggest that diet is not directly linked to 5-MeO-DMT production, and support the alternative hypotheses that Sonoran Desert toads synthesize 5-MeO-DMT endogenously or via a microbial symbiont.
Citations in the library
Cited by 2
Cites 5
- A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms. Psychopharmacology April 13, 2019
- Bufo alvarius: a potent hallucinogen of animal origin. Journal of Ethnopharmacology 1994
- A narrative synthesis of research with 5-MeO-DMT. Journal of Psychopharmacology March 1, 2022
- Indolealkylamines: Biotransformations and Potential Drug–Drug Interactions The AAPS Journal May 3, 2008
- 5-Methoxy- and 5-hydroxyindoles in the skin of Bufo alvarius. Biochemical Pharmacology July 1, 1967